BioSpace News Archive

Pharm Country

Infinity BiologiX’s RT-PCR Saliva Test to be Provided Free to New Jerseyans for At-Home Testing

Infinity BiologiX (“IBX”), a leader in analytics, bioprocessing and biobanking, is proud to have its RT-PCR COVID-19 saliva test provided for free at-home testing to New Jerseyans.

December 15, 2021
·
2 min read
Lone Star Bio

Greenwich LifeSciences CEO Participates in TD Ameritrade Interview to Discuss 2021 SABCS Poster

Greenwich LifeSciences, Inc. announced that CEO Snehal Patel participated in a TD Ameritrade interview to discuss the Phase IIb poster presented at the 2021 San Antonio Breast Cancer Symposium on December 9, 2021.

December 15, 2021
·
6 min read
Pharm Country

New Data Suggest COVAXIN™ (BBV152) Vaccine Candidate Generates Robust Immune Memory to COVID-19 and Variants of Concern for At Least Six Months After Vaccination

Ocugen, Inc. announced that data analyzing immune response following two doses of the vaccine candidate, COVAXIN™ (BBV152), from a third-party study were published on the preprint server, medRxiv.

December 15, 2021
·
9 min read
Job Trends

Lilly Highlights Innovation-based Growth Strategy and Pipeline Developments; Announces 2022 Financial Guidance at Investment Community Meeting

Eli Lilly and Company (NYSE: LLY) is providing extensive updates across its research and development (R&D) programs to highlight the company’s strong pipeline and potential for future growth.

December 15, 2021
·
17 min read
Pharm Country

NRx Pharmaceuticals Added to the Nasdaq® Biotech Index

NRx Pharmaceuticals announced that Nasdaq has added the company to the Nasdaq Biotechnology Index effective December 20, 2021.

December 15, 2021
·
3 min read
Clene Nanomedicine’s Patent Portfolio Grows to More Than 150 Issued Worldwide, including Two Key Patents Now Validated Across Europe

Clene Inc. announced it has validated key patents granted by the European Patent Office that protect the Company’s breakthrough processes, devices and methods for treating certain disease indications for its nanotherapeutic drugs.

December 15, 2021
·
6 min read
Drug Development

BioXcel Therapeutics Initiates Pivotal Phase 3 Program of BXCL501 for Acute Treatment of Agitation in Patients with Alzheimer’s Disease

BioXcel Therapeutics, Inc. today announced the initiation of its pivotal Phase 3 program for BXCL501, the Company’s proprietary, orally dissolving thin film formulation of dexmedetomidine, for the acute treatment of agitation in patients with Alzheimer’s disease (AD).

December 15, 2021
·
9 min read
Pharm Country

BeyondSpring Pharmaceuticals Announces New Clinical Data Confirming Plinabulin’s Fast Onset Mechanism of Action in the Prevention of Chemotherapy-Induced Neutropenia at the 63rd ASH Annual Meeting and Exposition

BeyondSpring Pharmaceuticals today announced new data highlighting the mechanism of action of plinabulin in the prevention of chemotherapy-induced neutropenia (CIN) at the 63rd American Society of Hematology (ASH) Annual Meeting and Exposition.

December 15, 2021
·
7 min read
Deals

Apeiron and Other Key Shareholders of atai Life Sciences Reinforce Support by Entering into Extended, Voluntary Share Lock-up Agreements

Apeiron and other key shareholders enter into voluntary lock-up agreements. This voluntary lock-up extends trading restrictions by 24 months for Apeiron and 12 months for other investors.

December 15, 2021
·
5 min read
Business

BioLineRx Announces Formation of Immuno-Oncology Scientific Advisory Board (SAB)

BioLineRx Ltd. today announced establishment of a Scientific Advisory Board (SAB) to provide insight and guidance on the Company’s activities in the field of immuno-oncology.

December 15, 2021
·
9 min read